| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.001 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.001 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |